Olaparib in combination with irinotecan, cisplatin, and mitomycin c in patients with advanced pancreatic cancer

Research output: Contribution to journalArticlepeer-review

35 Scopus citations

Fingerprint

Dive into the research topics of 'Olaparib in combination with irinotecan, cisplatin, and mitomycin c in patients with advanced pancreatic cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences